Therapeutic manipulation of NKT cells in autoimmunity

1 Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis Annals of Rheumatic Diseases, April 22, 2013    Evidence Based Medicine    Review Article

2 Interleukin-6: a new therapeutic target in systemic sclerosis Clinical & Translational Immunology, April 18, 2013    Review Article

3 New biologic therapy for systemic lupus erythematosus Current Opinion in Pharmacology , May 10, 2013

4 Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study Annals of Rheumatic Diseases, April 25, 2013

5 Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome Journal of Neural Transmission, April 30, 2013    Review Article

6 Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature Lupus, April 25, 2013

7 Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome Clinical and Experimental Nephrology, April 19, 2013

8 Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy, Canadian Journal of Gastroenterology, May 7, 2013

9 A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis Cancer Chemotherapy and Pharmacology, April 29, 2013

10 Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases Journal of the European Academy of Dermatology and Venereology, April 18, 2013